ABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
NCT05532722
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
T-cell Large Granular Lymphocytic Leukemia
Interventions
DRUG:
ABC008
Sponsor
Abcuro, Inc.